Proinflammatory cytokines increase in sepsis after anti-adhesion molecule therapy

Shock

Volumn 13, Issue 5, 2000, Pages 404-409

  Welty Wolf, Karen E ^a   Carraway, Martha S ^a   Ghio, Andrew ^a   Kantrow, Stephen P ^b   Huang, Yu Chin T ^a   Piantadosi, Claude A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Baboon; E selectin; Intercellular adhesion molecule 1; Interleukin 1 ; Interleukin 6; Interleukin 8; L selectin; Tumor necrosis factor receptor 1

Indexed keywords

AUTACOID; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL; ARTICLE; BLOOD; ENTEROBACTER INFECTION; ESCHERICHIA COLI; IMMUNOLOGY; MALE; PAPIO; PATHOGENICITY; SEPSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CYTOKINES; E-SELECTIN; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; L-SELECTIN; MALE; PAPIO; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEPSIS;

EID: 0034181970     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200005000-00010     Document Type: Article

References (40)

1. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL: Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 64:4733-4738, 1996.
2. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975-978, 1989.
3. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710, 1989.
4. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60:2835-2842, 1992.
5. Waage A, Halstensen A, Espevik T: Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet I:355-357, 1987.
6. Waage A, Brandtzaeg P, Halstensen A, Kierul FP, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169:333-338, 1989.
7. Halstensen A, Ceska M, Brandtzaeg P, Redl H, Noess A, Waage A: Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 167:471-475, 1993.
8. Creasey AA, Stevens P, Kenney J Allison AC, Warren K, Catlett R, Hinshaw L, Taylor FB Jr: Endotoxin and cytokine profile in plasma of baboons challenged with lethal or sublethal Escherichia coli. Circ Shock 33:84-91, 1991.
9. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-853, 1993.
10. Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Eng J Med 334:1717-1725, 1996.
11. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697-1702, 1996.
12. Bevilacqua MP, Stenglin S, Gimbrone MA Jr, Seed B: Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160-1165, 1989.
13. Tocci MJ, Schmidt JA: Interleukin 1: structure and function. In Remick DG, Friedland JS (eds): Cytokines in Health and Disease. New York: Marcel Dekker Inc, 1997, pp 1-28.
14. Tracey KJ: Tumor necrosis factor. In Remick DG, Friedland JS (eds): Cytokines in Health and Disease. New York:Marcel Dekker Inc, 1997, pp 223-240.
15. Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA Jr: Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 136:1680-1687, 1986.
16. Steinhauser ML, Kunkel SI, Hogabam CM, Evanoff H, Streiter RM, Lukacs NW: Macrophage/fibroblast coculture induces macrophage inflammatory protein-1α production mediated by intercellular adhesion molecule-1 and oxygen radicals. J Leuk Biol 64:636-641, 1998.
17. Boyd AW, Wawryk SO, Burns GF, Fecondo JV: Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci USA 85:3095-3099, 1988.
18. Waddell TK, Fialkow L, Chan CK, Kishimoto TK, Downey GP: Potentiation of the oxidative burst of human neutrophils: a signaling role for L-selectin. J Biol Chem 269:18485-18491, 1994.
19. Koyama Y, Tanaka Y, Saito K, Abe M, Nakatsuka K, Morimoto I, Auron PE, Eto S: Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1β transcription. J Immunol 157:5097-5103, 1996.
20. Sano H, Nakagawa N, Chiba R, Kurasawo K, Saito Y, Iwamoto I: Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem Biophys Res Commun 250:694-698, 1998.
21. Welty-Wolf KE, Carraway MS, Huang YCT, Simonson SG, Kantrow SP, Piantadosi CA: Bacterial priming increases lung injury in gram-negative sepsis. Am J Respir Crit Care Med 158:610-619, 1998.
22. Carraway MS, Welty-Wolf KE, Kantrow SP, Huang YCT, Simonson SG, Que LG, Kishimoto TK, Piantadosi CA: Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons. Am J Respir Crit Care Med 157:938-949, 1998.
23. Welty-Wolf KE, Carraway MS, Huang YCT, Simonson SG, Kantrow SP, Que LG, Piantadosi CA: Antibody to intercellular adhesion molecule-1 does not decrease lung injury in primates with Escherichia coli sepsis. Am J Respir Crit Care Med 155:A263, 1997.
24. Zimmerman GA, Lorant DE, McIntyre TM, Prescott SM: Juxtacrine intercellular signaling: another way to do it. Am J Respir Crit Care Med 9:573-577, 1993.
25. Redl H, Schlag G, Bahrami S, Schade U, Ceska M, Stutz P: Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. J Infect Dis 164:383-388, 1991.
26. Fischer E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, DeForge Km Kenney JS, Remick DG, Bloedow DC, Thompson RC, Lowry SF, Moldawer LL: Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 89: 1551-1557, 1992.
27. Espat NJ, Cendan JC, Beierle EA, Auffenberg TA, Rosenberg J, Russell D, Kenney JS, Fischer E, Montegut W, Lowry SF, Copeland EM, Moldawer LL: PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock. J Surg Res 59:153-158, 1995.
28. Van Zee KJ, Fischer E, Jawes AS, Hebert CA, Terrell TG, Baker JB, Lowry SF, Moldawer LL: Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1148:1746-1752, 1992.
29. Weinberg JR, Wright DJM, Guz A: Interleukin-1 and tumor necrosis factor cause hypotension in the conscious rabbit. Clin Sci 75:251-255, 1988.
30. Waage A, Redl H, Schlag G, Schade U. The cytokine network in sepsis II: IL-1 and IL-6. In Schlag G, Redl H (eds): Pathophysiology of Shock, Sepsis, and Organ Failure. Berlin: Springer-Verlag, 1993, pp 491-501.
31. Ridings PC, Windsor AC, Jutila MA, Blocher CR, Fisher BJ, Sholley MM, Sugarman HJ, Fowler AA III: A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury. Am J Respir Crit Care Med 152:247-253, 1995.
32. Zeni F, Parent C, Correa R, Natason C, Freeman B, Fontana J, Quezado M, Danner RL, Fitz Y, Richmond S, Gerstenberger E, Banks SM, Eichacker PQ. ICAM-1 and CD116 inhibition worsen outcome in rats with E. coli pneumonia. J Appl Physiol 87:299-307, 1999.
33. Van Zee KJ, Moldawer LL, Oldenburg HS, Thompson WA, Stackpole SA, Montegut WJ, Rogy MA, Meschter C, Galliti H, Schiller CD, Richter WF, Loescher H, Ashkenazi A, Chamow SM, Wurm F, Calvano SE, Lowry SF, Lesslauer W: Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081. J Immunol 156:2221-2230, 1996.
34. Schneider D, Berrouschot J, Brandt T, Hacke W, Ferbert A, Norris SH, Polmar SH, Schafer E: Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke. Eur Neurol 40:78-83, 1998.
35. Huag CE, Colvin RB, Delmonico FL, Auchincloss H, Tolkoff -Rubin N, Preffer FI, Rothlein R, Norris S, Scharschmidt L, Cosimi AB: A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766-773, 1993.
36. Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmict LA, Lipsky PE: Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 37:992-999, 1994.
37. Zimmerman GA, McIntyre TM, Prescott SM: Adhesion and signaling in vacsular cell-cell interactions. J Clin Invest 98:1699-1702, 1996.
38. Salomon B, Bluestone JA: Cutting edge: LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J Immunol 161:5138-5142, 1998.
39. Isobe M, Suzuki J, Yamazaki S, Yazaki Y, Horie S, Okubo Y, Maemura K, Yazaki Y, Sekiguchi M: Regulation by differential development of ThI and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion. Circulation 96:2247-2253, 1997.
40. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallman R, Scheffold A, Radbruch A, Hamann A: P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385:81-83, 1997.